{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:06:38Z","timestamp":1785521198904,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010431","name":"Institute of Medicine and Applied Epidemiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI164562"],"award-info":[{"award-number":["UM1AI164562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK131476"],"award-info":[{"award-number":["R01DK131476"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ebiom.2025.105672","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T01:06:39Z","timestamp":1743469599000},"page":"105672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Impact of rosuvastatin on the memory potential and functionality of CD8+ T cells from people with HIV"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0119-8306","authenticated-orcid":false,"given":"Federico","family":"Perdomo-Celis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-2521","authenticated-orcid":false,"given":"Caroline","family":"Passaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Monceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0765-0869","authenticated-orcid":false,"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu F.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-7536","authenticated-orcid":false,"given":"Asier","family":"S\u00e1ez-Ciri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2025.105672_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/imr.12076","article-title":"HIV controllers: a genetically determined or inducible phenotype?","volume":"254","author":"S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ebiom.2025.105672_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41577-020-0381-7","article-title":"Immunometabolism and HIV-1 pathogenesis: food for thought","volume":"21","author":"S\u00e1ez-Ciri\u00f3n","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib4","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2025.105672_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.136648","article-title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity","volume":"6","author":"Rutishauser","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.105672_bib6","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex\u00a0vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"Saez-Cirion","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105672_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s42255-019-0081-4","article-title":"Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection","volume":"1","author":"Angin","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.ebiom.2025.105672_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108174","article-title":"Optimal maturation of the SIV-specific CD8+ T cell response after primary infection is associated with natural control of SIV: ANRS SIC study","volume":"32","author":"Passaes","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2025.105672_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI157549","article-title":"Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control","volume":"132","author":"Perdomo-Celis","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105672_bib10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.105672_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.12902","article-title":"Immune modulatory effects of statins","volume":"154","author":"Zeiser","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2025.105672_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/infdis\/jiq115","article-title":"High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial","volume":"203","author":"Ganesan","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105672_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/QAI.0000000000000879","article-title":"Rosuvastatin is effective to decrease CD8 T-cell activation only in HIV-infected patients with high residual T-cell activation under antiretroviral therapy","volume":"71","author":"Weiss","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2025.105672_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105672_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1339338","article-title":"Effects of statins beyond lipid-lowering agents in ART-treated HIV infection","volume":"15","author":"Mehraj","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105672_bib18","article-title":"Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models","volume":"11","author":"Kansal","year":"2023","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.ebiom.2025.105672_bib19","doi-asserted-by":"crossref","first-page":"98215","DOI":"10.18632\/oncotarget.21003","article-title":"Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling","volume":"8","author":"Okoye","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2025.105672_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41590-022-01219-w","article-title":"\u2018Stem-like\u2019 precursors are the fount to sustain persistent CD8+ T cell responses","volume":"23","author":"Zehn","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib21","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1002042","article-title":"Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche","volume":"185","author":"Banerjee","year":"2010","journal-title":"Journal Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105672_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.20121190","article-title":"Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin","volume":"210","author":"Curran","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2025.105672_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105672_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41467-023-44389-3","article-title":"Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells","volume":"15","author":"Passaes","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105672_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12617","article-title":"Lipid rafts in immune signalling: current progress and future perspective","volume":"149","author":"Varshney","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2025.105672_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","article-title":"Statin effects on cholesterol micro-domains in brain plasma membranes","volume":"65","author":"Kirsch","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ebiom.2025.105672_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1096\/fj.04-2702fje","article-title":"Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases","volume":"19","author":"Ghittoni","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2025.105672_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105672_bib30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.humimm.2005.04.004","article-title":"Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains","volume":"66","author":"Kuipers","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib32","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","article-title":"Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity","volume":"22","author":"Guo","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2025.105672_bib33","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1084\/jem.20171576","article-title":"Cholesterol negatively regulates IL-9-producing CD8(+) T cell differentiation and antitumor activity","volume":"215","author":"Ma","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2025.105672_bib34","first-page":"219","article-title":"The role of cholesterol metabolism in cancer","volume":"9","author":"Ding","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ebiom.2025.105672_bib35","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105672_bib36","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004","article-title":"Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity","volume":"54","author":"Hanna","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105672_bib37","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood.V93.5.1506.405a38_1506_1510","article-title":"Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome","volume":"93","author":"Tan","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2025.105672_bib38","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1189\/jlb.0206113","article-title":"Human immunodeficiency virus infection and macrophage cholesterol metabolism","volume":"80","author":"Bukrinsky","year":"2006","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ebiom.2025.105672_bib39","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105672_bib40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2213-8587(24)00150-5","article-title":"Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial","volume":"12","author":"Eckard","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ebiom.2025.105672_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103270","article-title":"LILAC pilot study: effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy","volume":"65","author":"Planas","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105672_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.10.031","article-title":"High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients","volume":"144","author":"Cantini","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2025.105672_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-022-09385-8","article-title":"A\u00a0propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study","volume":"22","author":"Takada","year":"2022","journal-title":"BMC Cancer"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:48Z","timestamp":1762618608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S2352396425001161"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105672","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of rosuvastatin on the memory potential and functionality of CD8+ T cells from people with HIV","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105672"}}